European Interbalkan Medical Center

The 3rd Department of Oncology in Thessaloniki is focused on neoplasms, with clinical trials exploring new ways to treat and prevent cancer recurrence. The studies center on breast cancer and non-small cell lung cancer, aiming to improve survival, delay disease progression, and strengthen current standards of care.

• Research in ER+/HER2- early breast cancer is evaluating new endocrine-based therapy approaches to reduce the risk of recurrence.
• Trials in hormone receptor positive breast cancer are testing whether newer treatment combinations can improve disease control compared with existing options.
• Studies in non-small cell lung cancer are assessing immunotherapy-based strategies for patients with advanced or metastatic disease.

Overall, the site is contributing to research that compares emerging cancer treatments with standard therapies, with a strong emphasis on better long-term outcomes for patients.